India is one of the largest
exporters of pharmaceuticals and generic medicines in the world. The Indian Pharmaceutical sector has witnessed
steady growth over the years and is a significant contributor to the country’s
economy. For this growth to continue into the coming years, affordable and
reliable power is required for the Pharmaceutical Industry as power tariffs increase
every year, substantially impacting manufacturing costs. Many pharmaceutical
companies are committed to the cause of sustainability, not just in business
terms, but also in the environment sense by adopting innovative technologies to
reduce energy consumption and imbibing resource management practices in their
Pharmaceutical Industry requires
massive amounts of power for operating. One such large pharmaceutical company
decided to tackle the problem of increasing power tariffs by adopting a rooftop
solar power plant. U-Solar’s attractive OPEX offering made economic sense to
this fast growing company, wherein they did not have to invest towards
construction of the solar power plant, and are now enjoying the benefits of sourcing
solar energy. The company has signed a long term PPA with a 3rd
party power producer for procuring power at a rate that is 20-30% lower than the retail electricity price offered by the state DISCOM.
The 956 kWp
solar PV system that has been installed is a combination of ground-mount and
rooftop configuration. While 916 kWp solar PV system was setup on the ground
using 2820 nos. of high performance 325 Wp RenewSys poly-crystalline solar PV
modules, 8 nos. of 92 kW KACO string inverters. Likewise a 40 kWp PV system was
installed on the rooftop using 120 nos. of high performance 330 Wp RenewSys
poly-crystalline solar PV modules, 1 no. 22 kW Sungrow inverter. For data
monitoring and communication, WebdynSun Data Logger & Monitoring System has
been configured at the site to aid operation and maintenance of the solar power
plant. The plant was commissioned in the month of June 2019, built on a single
axis seasonal tracking system that improves the generation by 8-10%.
Industry in India is expected to grow to $55 bn. by 2020. Considering the
rising energy demands of the industry in tandem with escalating retail power
prices, the time is right for pharmaceutical companies to adopt solar energy.
The uptake of power from renewable sources like solar can happen at zero
capital investment by partnering with U-Solar and having a solar power plant
installed in your manufacturing/warehousing premises, without the hassle of
building, operating and maintaining the same.
If your organization is looking to adopt solar, please feel free to get in touch with us. We believe in partnering with our clients on their sustainability journey.
Email us at email@example.com
WhatsApp us at +916366226970 | https://wa.me/916366236970